AmbioPharm - A Global Peptide CDMO

Ambio Pharm A Global Peptide Cdmo

Pharmaceuticals, 1024 Dittman Court, North Augusta, South Carolina, 29842, United States, 501-1000 Employees

ambiopharm.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +18*********

Who is AMBIOPHARM - A GLOBAL PEPTIDE CDMO

AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for p...

Read More

map
  • 1024 Dittman Court, North Augusta, South Carolina, 29842, United States Headquarters: 1024 Dittman Court, North Augusta, South Carolina, 29842, United States
  • 2005 Date Founded: 2005
  • 501-1000 Employees: 501-1000
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AMBIOPHARM - A GLOBAL PEPTIDE CDMO

AmbioPharm - A Global Peptide CDMO Org Chart and Mapping

Employees

Allison Pearl

Purification Chemist II

Monica Goodson

Quality Assurance Supervisor

Mark Dafonseca

Executive Vice President of Global Business Development and Sales

Pat Coxon

Sales Manager - Central Us, Canada, Central/South America, Australia & New Zealand

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding AmbioPharm - A Global Peptide CDMO

Answer: AmbioPharm - A Global Peptide CDMO's headquarters are located at 1024 Dittman Court, North Augusta, South Carolina, 29842, United States

Answer: AmbioPharm - A Global Peptide CDMO's phone number is +18*********

Answer: AmbioPharm - A Global Peptide CDMO's official website is https://ambiopharm.com

Answer: AmbioPharm - A Global Peptide CDMO's revenue is $25 Million to $50 Million

Answer: AmbioPharm - A Global Peptide CDMO's SIC: 2834

Answer: AmbioPharm - A Global Peptide CDMO's NAICS: 325412

Answer: AmbioPharm - A Global Peptide CDMO has 501-1000 employees

Answer: AmbioPharm - A Global Peptide CDMO is in Pharmaceuticals

Answer: AmbioPharm - A Global Peptide CDMO contact info: Phone number: +18********* Website: https://ambiopharm.com

Answer: AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access